New Zealand targets medicinal cannabis foothold in Brazil market

New Zealand pursues share of Brazil's medicinal cannabis sector, signaling export ambitions as domestic regulatory framework stabilizes.

FILE — harvest · My 420 Tours / CC BY-SA 4.0

New Zealand is pursuing market entry in Brazil's medicinal cannabis sector, according to reporting from Sechat. The move reflects a shift toward international commercialization for the country's cannabis industry, which has spent recent years establishing domestic regulatory foundations—including hemp licensing reform and THC limits finalized in mid-2026.

New Zealand operators have begun building export distribution capabilities, most recently with Ora Pharm completing an acquisition of Helius to secure an export pathway. A domestic firm also secured its largest distribution deal to date in July 2026, suggesting growing operational scale among licensed producers. However, enforcement activity remains active: police conducted multiple raids on unlicensed grows through 2026, and a medicinal licensee faced arrest over alleged compliance breaches.

Brazil represents a high-stakes test for New Zealand's export strategy, given the country's large population and evolving medical cannabis regulations. Watch whether New Zealand operators establish formal distribution partnerships or regulatory approvals in Brazil, and whether domestic licensing enforcement evolves to support rather than hinder export-ready producers.